Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues. (Q55470203)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2006

Language	Label	Description	Also known as
English	Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues.	scientific article published in April 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

author name string

Xie F

1

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Wang Q

2

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Chen Y

3

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Gu Y

4

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Shi Q

5

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Ge Y

6

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Yu G

7

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Wu H

8

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Mao Y

9

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Wang X

10

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Zhou Y

11

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Zhang X

12

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Tissue Antigens

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

67

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

4

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

307-317

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Identification of rat OX40 ligand by molecular cloning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

OX40: targeted immunotherapy--implications for tempering autoimmunity and enhancing vaccines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

CD134/OX40 expression by synovial fluid CD4+ T lymphocytes in chronic synovitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Time courses of B7 family molecules expressed on activated T-cells and their biological significance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Production of monoclonal antibodies: strategy and tactics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Induction of anti-mammary cancer immunity by engaging the OX-40 receptor in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Prospects for CD40-directed experimental therapy of human cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

The CD40/CD154 receptor/ligand dyad

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Characterization and functional study of five novel monoclonal antibodies against human OX40L highlight reverse signalling: enhancement of IgG production of B cells and promotion of maturation of DCs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Engagement of the OX-40 receptor in vivo enhances antitumor immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2006.00584.X

21 January 2018

Identifiers

10.1111/J.1399-0039.2006.00584.X

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/16634867

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55470203&oldid=1364904570"